To further our mission, we annually award research grants to institutions and medical professionals whose research focuses on cancers that present the greatest opportunities for a homerun cancer cure.
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
The Cure Starts Now has funded over $14 million in partnership with the DIPG Collaborative. This includes 90+ grants at over 100 hospitals in 15 countries.
St. Jude Children's Research Hospital - $35,000
Imaging to Discern Immunotherapeutic-induced Pseudoprogression in CNS Tumors.
Johns Hopkins Children's Center - $50,000
Using Zebrafish to Accelerate DIPG Drug Development.
The Campbell Family Institute for Cancer Research - $100,000
Defining the molecular mechanisms of DIPG development and progression to uncover novel therapeutic targets
The Regents of the University of California - $70,000
An Open Label Single Arm Phase I/II study of MTX110 delivered by convection-enhanced delivery (CED) in patients with diffuse intrinsic pontine glioma (DIPG) previously treated with external beam radiation therapy
The Hospital for Sick Children - $100,560
MRI Guided Focused Ultrasound: Towards Clinical Translation in Diffuse Intrinsic Pontine Glioma (DIPG)
Texas Children's Hospital and Ann & Robert H. Lurie Children's Hospital of Chicago - $200,000
Targeting DIPG through Combining a Super-activator (MCB-613) of Steroid Receptor Co-activators with Radiation.
Gustave Roussy - $101,868
Elucidating the underlying mechanisms of radio resistance at diagnosis and relapse in DIPG